APA (7th ed.) Citation

Furlanetto, J., Denkert, C., Untch, M., Sinn, B., Lederer, B., Schneeweiss, A., . . . Loibl, S. (2021). 17P Impact of body mass index (BMI) on prognostic and predictive value of stromal tumour-infiltrating lymphocytes (sTILs) in triple-negative breast cancer (TNBC): A pooled analysis of six neoadjuvant trials. Annals of Oncology, 32, S27. https://doi.org/10.1016/j.annonc.2021.03.031

Chicago Style (17th ed.) Citation

Furlanetto, J., et al. "17P Impact of Body Mass Index (BMI) on Prognostic and Predictive Value of Stromal Tumour-infiltrating Lymphocytes (sTILs) in Triple-negative Breast Cancer (TNBC): A Pooled Analysis of Six Neoadjuvant Trials." Annals of Oncology 32 (2021): S27. https://doi.org/10.1016/j.annonc.2021.03.031.

MLA (9th ed.) Citation

Furlanetto, J., et al. "17P Impact of Body Mass Index (BMI) on Prognostic and Predictive Value of Stromal Tumour-infiltrating Lymphocytes (sTILs) in Triple-negative Breast Cancer (TNBC): A Pooled Analysis of Six Neoadjuvant Trials." Annals of Oncology, vol. 32, 2021, p. S27, https://doi.org/10.1016/j.annonc.2021.03.031.